Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer

NCT00050297 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00050297
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00050297 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
YM598 in Patients With Rising PSA After Initial Therapy for Localized Prostate Cancer
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Terminated
Start date
Not reported
Completion date
February 29, 2004
Enrollment
Not reported
Sites
23

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer